prolaio eVO2peak Module vs AI-ECG Tracker
AI Verdict
Choose prolaio eVO2peak Module if…
Choose Prolaio eVO2peak Module if your primary need is to longitudinally monitor and estimate peak oxygen consumption (eVO2peak) using real-world data from qualified third-party wearable medical sensors. This tool is ideal for cardiovascular research and care settings requiring high-density, continuous functional capacity assessment as an adjunctive aid in clinical evaluation.
View prolaio eVO2peak Module →Choose AI-ECG Tracker if…
Choose AI-ECG Tracker if your priority is rapid and highly accurate AI-powered auto-analysis and diagnosis of 12-lead ECGs for common cardiac abnormalities. This solution is best suited for clinical environments, such as emergency medicine or cardiology, where quick identification of conditions like arrhythmias, myocardial ischemia, or infarction is critical for diagnostic support.
View AI-ECG Tracker →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | prolaio eVO2peak Module | AI-ECG Tracker |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | Cloud-based (software-only, processes remote sensor data) | Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
prolaio eVO2peak ModuleTool A is described as cloud-based and software-only, processing remote sensor data, which generally implies a simpler deployment and potentially more streamlined user experience for data input. Tool B, while offering rapid diagnosis, involves an on-premise workstation and a Windows-based client, which might introduce more setup complexity compared to a purely cloud-based solution.
Clinical Value
AI-ECG TrackerTool B offers high-accuracy (over 95%) AI-powered auto-analysis and diagnosis for a comprehensive range of 16 cardiac classifications and 104 ECG diagnostic classifications, directly supporting diagnostic decisions. Tool A, while valuable, provides an estimation of eVO2peak as an adjunctive aid in clinical evaluation, which serves a more supportive rather than direct diagnostic role.
Pricing & Value
TieBoth tools lack publicly available pricing information, making a direct comparison of their cost impossible. Without transparent pricing, it is not feasible to accurately assess which tool offers better value for its features and capabilities.
Enterprise Readiness
AI-ECG TrackerTool B demonstrates strong enterprise readiness with its AI-ECG Workstation, a web-based Management Portal for organization settings, security, and task management, and its backing by a large international medical device company, Lepu Medical. While Tool A explicitly states HIPAA compliance and BAA availability, Tool B's comprehensive management features and flexible deployment options (on-premise and cloud) provide a more robust offering for large-scale organizational integration.
Innovation
prolaio eVO2peak ModuleTool A exhibits greater innovation by estimating peak oxygen consumption (eVO2peak) using real-world data from qualified third-party FDA-cleared wearable medical sensors, combining demographic data, single-lead ECG, and triaxial accelerometry inputs. This approach of leveraging diverse and potentially more accessible longitudinal data sources for a complex physiological estimation is a novel application of AI in cardiology.
Support & Docs
AI-ECG TrackerTool B, through its parent company Lepu Medical, indicates a more structured support ecosystem with mentions of a 'Download Center,' 'Video Center,' and 'Online technical support' for related products. While Tool A provides contact information and states ISO certification for support, Tool B's broader range of documented resources suggests more comprehensive support and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | prolaio eVO2peak Module | AI-ECG Tracker |
|---|---|---|
| Name | prolaio eVO2peak Module | AI-ECG Tracker |
| Company | Prolaio | Shenzhen Carewell Electronics Co. |
| Description | FDA-cleared software to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care. | Pioneer in applying artificial intelligence technology to ECG auto-diagnosis, distributing innovative AI medical devices to over 100 countries. |
| Key Features | Estimates peak oxygen consumption (eVO2peak); Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs; Processes data from qualified third-party FDA-cleared wearable medical sensors; Applies a locked deep-learning model for eVO2peak estimation; Provides information as an adjunctive aid in clinical evaluation; Enables high-density, longitudinal data collection; Leverages real-world patient data and insights; Features FDA-cleared software and proprietary algorithms. | AI-powered ECG auto-analysis and diagnosis; High accuracy (over 95%) for common cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction; Supports 12-lead ECG data collection; AI-ECG Workstation with powerful GPU for fast computing; Web-based Management Portal for organization settings, security, and task management; Window-based professional ECG diagnostic client for review, measurement, annotation, and report generation; Rapid diagnosis in approximately 3 seconds; Comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications. |
| Specialties | Cardiology, Physical Medicine & Rehab, Sports Medicine | Cardiology, Emergency Medicine |
Videos
Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and AI-ECG Tracker.